You just read:

Prometic's PBI-4050 Receives Promising Innovative Medicine (PIM) Designation From The UK MHRA In The Treatment Of Idiopathic Pulmonary Fibrosis

News provided by

ProMetic Life Sciences Inc.

Dec 11, 2017, 06:00 EST